Your browser doesn't support javascript.
loading
Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
Zhong, Xin-Cheng; Xu, Wen-Hong; Wang, Zi-Ting; Guo, Wang-Wei; Chen, Jie-Jian; Guo, Ning-Ning; Wang, Tian-Tian; Lin, Meng-Ting; Zhang, Zhen-Tao; Lu, Yi-Ying; Yang, Qi-Yao; Han, Min; Xu, Dong-Hang; Gao, Jian-Qing.
Afiliación
  • Zhong XC; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Xu WH; b Department of Radiation Oncology, Ministry of Education Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, College of Medicine , Zhejiang University , Hangzhou , People's Republic of China.
  • Wang ZT; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Guo WW; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Chen JJ; b Department of Radiation Oncology, Ministry of Education Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, College of Medicine , Zhejiang University , Hangzhou , People's Republic of China.
  • Guo NN; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Wang TT; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Lin MT; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Zhang ZT; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Lu YY; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Yang QY; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Han M; a Institute of Pharmaceutics, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Xu DH; c Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , People's Republic of China.
  • Gao JQ; d Department of Pharmacy, The 2nd Affiliated Hospital, School of Medicine , Zhejiang University , Hangzhou , China.
Drug Dev Ind Pharm ; 45(9): 1556-1564, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31271317
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos Organofosforados / Neoplasias de la Mama / Doxorrubicina / Nanoconjugados / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Drug Dev Ind Pharm Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos Organofosforados / Neoplasias de la Mama / Doxorrubicina / Nanoconjugados / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Drug Dev Ind Pharm Año: 2019 Tipo del documento: Article